Use of Atypical Antipsychotics in Children with Mental Retardation, Autism, and Other Developmental Disabilities
1997; Slack Incorporated (United States); Volume: 27; Issue: 3 Linguagem: Inglês
10.3928/0048-5713-19970301-15
ISSN1938-2456
Autores Tópico(s)Adolescent and Pediatric Healthcare
ResumoMENTAL RETARDATIONUse of Atypical Antipsychotics in Children with Mental Retardation, Autism, and Other Developmental Disabilities Mark Rubin, MD, , MD Mark Rubin, MD Psychiatric Annals, 2013;27(3):219–221Published Online:March 01, 1997https://doi.org/10.3928/0048-5713-19970301-15Cited by:14View Full TextPDF ToolsAdd to favoritesDownload CitationsTrack Citations ShareShare onFacebookTwitterLinkedInRedditEmail SectionsMore1. Menolascino FJ, Wilson J, Golden CJ, Ruedrich SL. Medication and treatment of schizophrenia in persons with mental retardation. Ment Retard. 1986; 24:277-283. Google Scholar2. Findling RL, Grcevich SJ, Lopez I, Schulz SC. Antipsychotic medications in children and adolescents. J Clin Psychiatry. 1996; 57(suppl 9): 19-23. Google Scholar3. Buzan RD. Risperidone induced tardive dyskinesia. Am J Psychiatry. 1996; 153:734-735. Google Scholar4. Zuddas A, Ledda MG, Fratta A, et al. Clinical effects of clozapine on autistic disorder. Am J Psychiatry. 1996; 153:738." Google Scholar5. Songer DA, Roman B. Treatment of somatic delusional disorder with atypical antipsychotic agents. Am J Psychiatry. 1996;153:578-579. Google Scholar6. Hölzer JC, Jacobson SA, Folstein MF. Treating compulsive self-mutilation in a mentally retarded patient. Am J Psychiatry. 1996; 153:133. Google Scholar7. Hammock RG, Schroeder SR, Stephen R, Levine WR. The effect of clozapine on self injurious behavior. J Autism Dev Disord. 1995; 25:611-626. Google Scholar8. Atlas JA, Gerbino-Rosen G. Differential diagnosis and treatment of an inpatient adolescent showing pervasive developmental disorder and mania. Psychol Rep. 1995; 77:207-210. Google Scholar9. Williams DE, Kirkpatrick-Sanchez S, et al. An evaluation of clozapine combined with behavioral intervention in the treatment of aggression and tantrums in a woman with mental retardation and schizophrenia. Journal of Developmental & Physical Disabilities. 1995; 7:155-160. Google Scholar10. Lit W, Labelle A, Jones BD, et al. Risperidone in the treatment of pervasive developmental disorder. Can J Psychiatry. 1994; 39;400-405. Google Scholar11. Pary RJ. Clozapine in three individuals with mild mental retardation and treatment-refractory psychiatry disorders. Ment Retará. 1994; 32:323-327. Google Scholar12. Sajatovic M, Ramirez LF, Kenny JT, Meltzer HY. The use of clozapine in borderline-intellectual-functioning and mentally retarded schizophrenic patients. Compr Psychiatry. 1994; 35:29-33. Google Scholar13. Vanden Borre R, Vermote R, Buttiens M, et al. Risperidone as add on therapy in behavioral disturbances in mental retardation: a double blind placebo-controlled cross-over study. Acta Psychiatr Scand. 1993; 87:167-171. Google Scholar14. Cohen SA, Underwood MT. The use of clozapine in a mentally retarded and aggressive population. J Clin Psychiatry. 1994; 55:440-444. Google Scholar15. Fieman S, Steele M, Short J, Byrne T, Lavallee C. Case study: anorexia nervosa and autistic disorder in an adolescent girl. J Am Acad Child Adolesc Psychiatry. 1996; 35:937-940. Google Scholar16. McDougle CJ, Brodkin ES, Yeung PP, Naylor ST, Cohen DJ, Price LH. Risperidone in adults with autism or pervasive developmental disorder. Journal of Child & Adolescent Psychopharmacology. 1995; 5:273-282. Google Scholar17. Harden A, Johnson K, Johnson C, Hrecznyj B. Case study: risperidone treatment of children and adolescents with developmental disorders. J Am Acad Child Adolesc Psychiatry. 1996;35:1551-1556. Google Scholar18. Purdon SE, Lit W, LaBeIIe A, Jones B. Risperidone in the treatment of pervasive developmental disorder. Can J Psychiatry. 1994; 39:400-405. Google Scholar19. Simeon JG, Carrey NJ, Wiggins DM, Milin RP, Hosenbocus SN. Risperidone effects in treatmentresistant adolescents; preliminary case reports. Journal of Child and Adolescent Psychopharmacology. 1995; 5:69-79. Google Scholar20. Schroeder SR, Hammock RG, Mulick JA, et al. Clinical trials of Dl and D2 dopamine modulating drugs and self injury in mental retardation and developmental disability. Mental Retardation and Developmental Disabilities Research Reviews. 1995; 1:120-129. Google Scholar21. Vyncke J. The treatment of behavior disorders in idiocy and imbecility with clozapine. J Pharmakopsychiatr Neuropsychopharmakol. 1974; 7:225-229. Google Scholar22. Rubin M, Langa A. Clozapine, mental retardation, and severe psychiatric illness: clinical response in the first year. Harvard Review of Psychiatry. 1995; 2:293-294. Google Scholar23. Burke MS, Josephson A, Sebastian CS, Schulman S. Clozapine and cognitive function. J Am Acad Child Adolesc Psychiatry. 1995; 34:127-128. Google Scholar24. Rapaport JL. Clozapine and child psychiatry. Journal of Child & Adolescent Psychopharmacology. 1994; 4:1-3. Google Scholar Previous article Next article FiguresReferencesRelatedDetailsCited by Scahill L and Martin A (2005) Psychopharmacology Handbook of Autism and Pervasive Developmental Disorders, 10.1002/9780470939352.ch18, (1102-1117), Online publication date: 15-Apr-2005. Handen B and Lubetsky M (2005) Pharmacotherapy in Autism and Related Disorders., School Psychology Quarterly, 10.1521/scpq.20.2.155.66514, 20:2, (155-171) Masi G (2004) Pharmacotherapy of Pervasive Developmental Disorders in Children and Adolescents, CNS Drugs, 10.2165/00023210-200418140-00006, 18:14, (1031-1052), . Miangolarra Page J, Carratalá Tejada M, Luna Oliva L and Pérez de Heredia M (2003) Síndrome de Rett: Actualización del proceso de rehabilitación, Rehabilitación, 10.1016/S0048-7120(03)73345-3, 37:2, (93-102), Online publication date: 1-Jan-2003. Stigler K, Posey D and McDougle C (2014) Recent advances in the pharmacotherapy of autism, Expert Review of Neurotherapeutics, 10.1586/14737175.2.4.499, 2:4, (499-510), Online publication date: 1-Jul-2002. MALONE R, CATER J, SHEIKH R, CHOUDHURY M and DELANEY M (2001) Olanzapine Versus Haloperidol in Children With Autistic Disorder: An Open Pilot Study, Journal of the American Academy of Child & Adolescent Psychiatry, 10.1097/00004583-200108000-00009, 40:8, (887-894), Online publication date: 1-Aug-2001. Goodnick P and Barrios C (2005) Use of olanzapine in non-psychotic psychiatric disorders, Expert Opinion on Pharmacotherapy, 10.1517/14656566.2.4.667, 2:4, (667-680), Online publication date: 1-Apr-2001. Tollefson G and Taylor C (2006) Olanzapine: Preclinical and Clinical Profiles of a Novel Antipsychotic Agent, CNS Drug Reviews, 10.1111/j.1527-3458.2000.tb00155.x, 6:4, (303-363) Matson J, Bamburg J, Mayville E, Pinkston J, Bielecki J, Kuhn D, Smalls Y and Logan J (2000) Psychopharmacology and mental retardation: a 10 year review (1990–1999), Research in Developmental Disabilities, 10.1016/S0891-4222(00)00042-1, 21:4, (263-296), Online publication date: 1-Jul-2000. McDougle C, Scahill L, McCracken J, Aman M, Tierney E, Arnold L, Freeman B, Martin A, McGough J, Cronin P, Posey D, Riddle M, Ritz L, Swiezy N, Vitiello B, Volkmar F, Votolato N and Walson P (2000) Research Units on Pediatric Psychopharmacology (Rupp) Autism Network, Child and Adolescent Psychiatric Clinics of North America, 10.1016/S1056-4993(18)30142-1, 9:1, (201-224), Online publication date: 1-Jan-2000. Potenza M, Holmes J, Kanes S and McDougle C (1999) Olanzapine Treatment of Children, Adolescents, and Adults with Pervasive Developmental Disorders, Journal of Clinical Psychopharmacology, 10.1097/00004714-199902000-00008, 19:1, (37-44), Online publication date: 1-Feb-1999. Stein D and Simeon D (1998) Pharmacotherapy of Stereotypic Movement Disorders, Psychiatric Annals, 10.3928/0048-5713-19980601-10, 28:6, (327-331), Online publication date: 1-Jun-1998. Grossman R and Verobvey L (1998) The Neurobiology of Stereotypic Behaviors and Stereotypic Movement Disorders, Psychiatric Annals, 10.3928/0048-5713-19980601-09, 28:6, (317-323), Online publication date: 1-Jun-1998. Potenza M and Mcdougle C (2014) The Role of Serotonin in Autism-Spectrum Disorders, CNS Spectrums, 10.1017/S1092852900004880, 2:5, (25-42), Online publication date: 1-May-1997. Request Permissions InformationCopyright 2013, SLACK IncorporatedPDF download • 6.2 MB Published online3/01/97
Referência(s)